Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AMAG Pharmaceuticals Inc. (AMAG)

8.91   0.03 (0.34%) 02-14 16:00
Open: 8.84 Pre. Close: 8.88
High: 8.99 Low: 8.53
Volume: 447,348 Market Cap: 302M
AMAG Pharmaceuticals Inc is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and to aid in the diagnosis of cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.495 - 9.542 9.542 - 9.589
Low: 8.429 - 8.473 8.473 - 8.519
Close: 8.836 - 8.909 8.909 - 8.983

Technical analysis

as of: 2020-02-14 4:26:30 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 13.07     One year: 15.00
Support: Support1: 8.53    Support2: 7.10
Resistance: Resistance1: 11.19    Resistance2: 12.84
Pivot: 9.17
Moving Average: MA(5): 9.15     MA(20): 9.69
MA(100): 10.91     MA(250): 11.05
MACD: MACD(12,26): -0.63     Signal(9): -0.64
Stochastic oscillator: %K(14,3): 19.19     %D(3): 20.20
RSI: RSI(14): 36.47
52-week: High: 16.20  Low: 6.81  Change(%): -44.3
Average Vol(K): 3-Month: 71830  10-Days: 45275

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AMAG has closed above bottom band by 27.9%. Bollinger Bands are 54.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to AMAG's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

AMAG Pharmaceuticals (AMAG) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
AMAG Pharmaceuticals (AMAG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMAG Pharmaceuticals : Files Response to Citizen Petition | MarketScreener
Today, AMAG Pharmaceuticals, Inc. submitted its response with the U.S. Food and Drug Administration to a petition filed by… | January 21, 2020

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 33.92
Shares Float (M) 15.99
% Held by Insiders 1.57
% Held by Institutions 130.46
Shares Short (K) 15110
Shares Short P. Month (K)

Stock Financials

EPS -8.450
Book Value (p.s.) 14.170
PEG Ratio 0.10
Profit Margin -88.55
Operating Margin -32.60
Return on Assets (ttm) -6.1
Return on Equity (ttm) -46.2
Qtrly Rev. Growth -31.2
Gross Profit (p.s.) 6.787
Sales Per Share
EBITDA (p.s.) -2.759
Qtrly Earnings Growth
Operating Cash Flow (M) -129.82
Levered Free Cash Flow (M) -85.98

Stock Valuations

P/E -1.05
P/E Growth Ratio
P/BV 0.63
P/S 0.93
P/CF -2.33

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio 1.5
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.